Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HCA | Common Stock | Options Exercise | $1.32M | +35.6K | +155.63% | $37.18 | 58.5K | Oct 27, 2022 | Direct | |
transaction | HCA | Common Stock | Tax liability | -$3.86M | -17.7K | -30.26% | $217.77 | 40.8K | Oct 27, 2022 | Direct | |
holding | HCA | Common Stock | 40.6K | Oct 27, 2022 | By MAM Trust (Spouse, Trustee) | ||||||
holding | HCA | Common Stock | 44.5K | Oct 27, 2022 | By MRM Trust (Spouse, Trustee) | ||||||
holding | HCA | Common Stock | 40.6K | Oct 27, 2022 | By TCM Trust (Spouse, Trustee) | ||||||
holding | HCA | Common Stock | 51.1K | Oct 27, 2022 | By 2018 GRAT | ||||||
holding | HCA | Common Stock | 76.1K | Oct 27, 2022 | By 2020 GRAT | ||||||
holding | HCA | Common Stock | 100K | Oct 27, 2022 | By 2021 GRAT |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HCA | Stock Appreciation Right | Options Exercise | $0 | -35.6K | -100% | $0.00* | 0 | Oct 27, 2022 | Common Stock | 35.6K | $37.18 | Direct | F1 |
Id | Content |
---|---|
F1 | The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. |